OPKO Health (OPK) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.64 +1.86%
EPS Growth %: -333.3%
Financial Fact:
Selling, general and administrative: 124.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -333.3%
Financial Fact:
Selling, general and administrative: 124.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $263.7 million versus the consensus estimate of $261.65 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
- Ardent Health revises 2025 non-GAAP figures after SEC staff talks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
